| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| Aging and the Growth of Long-Term Care |
0 |
0 |
1 |
242 |
0 |
0 |
2 |
1,286 |
| Aging and the Growth of Long-Term Care |
0 |
0 |
0 |
29 |
0 |
1 |
1 |
134 |
| An Economic Evaluation of the War on Cancer |
0 |
0 |
0 |
95 |
0 |
1 |
3 |
354 |
| Are the Young Becoming More Disabled? |
0 |
0 |
0 |
93 |
0 |
0 |
0 |
344 |
| Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer |
0 |
0 |
1 |
152 |
0 |
0 |
3 |
538 |
| Does Medicare Benefit the Poor? New Answers to an Old Question |
0 |
0 |
0 |
67 |
0 |
1 |
2 |
375 |
| Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? |
0 |
0 |
0 |
23 |
0 |
0 |
2 |
35 |
| Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? |
0 |
0 |
0 |
85 |
0 |
1 |
3 |
32 |
| Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey |
0 |
0 |
2 |
55 |
1 |
8 |
37 |
215 |
| Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? |
0 |
0 |
0 |
5 |
0 |
0 |
2 |
29 |
| Effects of expanding health screening on treatment – What should we expect? What can we learn? |
0 |
0 |
1 |
6 |
0 |
0 |
2 |
49 |
| Evaluation of Medical Technologies with Uncertain Benefits |
0 |
0 |
0 |
48 |
0 |
0 |
5 |
41 |
| Food Prices and the Dynamics of Body Weight |
0 |
0 |
3 |
70 |
0 |
1 |
7 |
229 |
| HIV Breakthroughs and Risk Sexual Behavior |
0 |
0 |
0 |
84 |
0 |
0 |
2 |
629 |
| Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses |
0 |
0 |
0 |
13 |
0 |
0 |
1 |
50 |
| Health Insurance as a Two-Part Pricing Contract |
0 |
0 |
0 |
97 |
0 |
1 |
1 |
421 |
| Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data |
0 |
0 |
0 |
52 |
1 |
1 |
1 |
189 |
| Insurance and Innovation in Health Care Markets |
0 |
0 |
1 |
136 |
0 |
0 |
2 |
465 |
| Insurance, Self-Protection, and the Economics of Terrorism |
0 |
0 |
0 |
287 |
0 |
0 |
0 |
884 |
| Insurer Bargaining and Negotiated Drug Prices in Medicare Part D |
0 |
0 |
0 |
32 |
2 |
2 |
3 |
145 |
| Insurers' Negotiating Leverage and the External Effects of Medicare Part D |
0 |
0 |
0 |
14 |
0 |
0 |
0 |
95 |
| Insurers’ Negotiating Leverage and the External Effects of Medicare Part D |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
69 |
| Intellectual Property and Marketing |
0 |
0 |
1 |
91 |
0 |
1 |
15 |
384 |
| International Differences in Longevity and Health and Their Economic Consequences |
0 |
0 |
0 |
35 |
0 |
0 |
0 |
122 |
| International Differences in Longevity and Health and their Economic Consequences |
0 |
0 |
0 |
51 |
0 |
1 |
3 |
259 |
| International Differences in Longevity and Health and their Economic Consequences |
0 |
0 |
0 |
54 |
0 |
0 |
1 |
167 |
| Mortality Risk, Insurance, and the Value of Life |
0 |
0 |
2 |
37 |
0 |
0 |
10 |
41 |
| Nonprofit Production |
0 |
0 |
0 |
0 |
0 |
1 |
7 |
194 |
| Nonprofit Production and Competition |
0 |
0 |
1 |
294 |
0 |
0 |
2 |
1,230 |
| Optimal Liability for Terrorism |
0 |
0 |
0 |
40 |
1 |
1 |
3 |
211 |
| Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D |
1 |
1 |
1 |
22 |
1 |
2 |
9 |
83 |
| The Declining Quality of Teachers |
0 |
0 |
0 |
220 |
0 |
0 |
2 |
1,667 |
| The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination |
0 |
0 |
3 |
489 |
0 |
0 |
18 |
1,590 |
| The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination |
0 |
0 |
1 |
88 |
0 |
0 |
5 |
364 |
| The Insurance Value of Medical Innovation |
0 |
0 |
1 |
31 |
0 |
0 |
4 |
95 |
| The Rise in Old Age Longevity and the Market for Long-Term Care |
0 |
0 |
1 |
233 |
1 |
1 |
2 |
1,766 |
| The Rise in Old Age Longevity and the Market for Long-Term Care |
0 |
0 |
0 |
0 |
1 |
1 |
7 |
765 |
| The Value of Medican and Pharmaceutical Interventions for Reducing Obesity |
0 |
0 |
1 |
29 |
1 |
1 |
3 |
158 |
| The Welfare Effects of Medical Malpractice Liability |
0 |
0 |
0 |
101 |
0 |
2 |
3 |
461 |
| The Welfare Effects of Public Drug Insurance |
0 |
0 |
0 |
77 |
0 |
0 |
0 |
284 |
| Time-Inconsistency and Welfare |
0 |
0 |
0 |
78 |
0 |
1 |
1 |
368 |
| Understanding Health Disparities Across Education Groups |
0 |
0 |
0 |
390 |
0 |
1 |
8 |
1,681 |
| Understanding the Economic Consequences of Shifting Trends in Population Health |
0 |
0 |
0 |
36 |
0 |
0 |
0 |
111 |
| Understanding the Economic Consequences of Shifting Trends in Population Health |
0 |
0 |
0 |
50 |
0 |
0 |
0 |
177 |
| Understanding the Economic Consequences of Shifting Trends in Population Health |
0 |
0 |
0 |
42 |
0 |
0 |
2 |
222 |
| Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market |
0 |
0 |
0 |
15 |
0 |
4 |
10 |
93 |
| Vaccine Allocation Priorities Using Disease Surveillance and Economic Data |
0 |
0 |
2 |
2 |
1 |
3 |
11 |
11 |
| Total Working Papers |
1 |
1 |
23 |
4,193 |
10 |
37 |
205 |
19,112 |
LogEc is hosted by the
Örebro University School of Business.